TokenPost·
Acumen Shares Fall More Than 80% After Alzheimer’s Trial Miss
The midstage ALTITUDE-AD study tested sabirnetug. Acumen had $78.6 million in cash, cash equivalents and marketable securities as of Sept. 30.
More news
- TokenPost1INCH Falls 13% After 1inch Says Token Was Stolen From Binance
- Crypto BriefingBitcoin short-term holders sell at loss for first time in 72 days
- TokenPostAdrian Flux Adds Humanoid Robot Coverage to UK Home Insurance
- TokenPostFBI Coordinates With Partners to Assess Binance Hack’s Potential Impact
- TokenPostRealty Income Q3 Results Due Monday as Analysts Forecast $1.45B in Revenue
- Bitcoin.com NewsBitcoin ETFs Add $441M in 4 Days as Zcash Streak Hits Day 8